Rituximab-Induced Hypersensitivity Pneumonitis

Rituximab is a chimeric anti-CD20 monoclonal antibody used to treat CD20+ non-Hodgkin's lymphoma. Although pulmonary adverse reactions such as cough, rhinitis, bronchospasm, dyspnea and sinusitis are relatively common, other respiratory conditions like cryptogenic organizing pneumonia, intersti...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tonelli, Adriano R., Lottenberg, Richard, Allan, Robert W., Sriram, P.S.
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2009
Témata:
Novel Insights from Clinical Practice
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2790794/
https://ncbi.nlm.nih.gov/pubmed/18843175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000163069
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky